Regulatory product record
STRONGER IODINE TCT
Product identity, ingredients and source provenance from the regulatory catalogue. Linked clinical evidence has a separate review status.
Product identity
- Brand name
- STRONGER IODINE TCT
- DIN
- 00349704
- DPD drug code
- 2253
- Regulatory category
- APPROVED_VET_DRUG
- Market status
- MARKETED
- Route(s)
- TOPICAL
- Pharmaceutical form(s)
- LIQUID
- Ingredients
- POTASSIUM IODIDE (5 %), IODINE (7 %)
- Species (DPD record)
- DOGS, CATS
- Company
- DOMINION VETERINARY LABORATORIES LTD. (DIN owner)
Source and provenance
- Source dataset
- health_canada_dpd_marketed
- Source snapshot date
- Not available in this source
- Source record key
- 2253
- Archive fingerprint (SHA-256)
- 85cc3ce208af3aa57018c3d14d83f90220c436baef7455384b6d48d9774e1c88
Linked clinical reference
Clinical entries are linked through the active molecule. Check their species, formulation, source and review status separately from this product record.
Clinical evidence
Dose regimens0
No dose regimens recorded for this species selection.
Adverse effects208
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsDog
- Vomiting10 reports
- Lack of efficacy - NOS7 reports
- Other abnormal test result NOS6 reports
- Elevated serum alkaline phosphatase (SAP)5 reports
- Ataxia4 reports
- Ear discharge4 reports
- Elevated alanine aminotransferase (ALT)4 reports
- Neutrophilia4 reports
- Behavioural disorder NOS3 reports
- Bruising3 reports
- Diarrhoea3 reports
- Head tilt - ear disorder3 reports
Cat
- Lethargy (see also Central nervous system depression in 'Neurological')7 reports
- Anorexia4 reports
- Behavioural disorder NOS4 reports
- Diarrhoea4 reports
- Other abnormal test result NOS4 reports
- Weight loss4 reports
- Anaemia NOS3 reports
- Death3 reports
- Lack of efficacy - NOS3 reports
- Seizure NOS3 reports
- Dehydration2 reports
- Diabetes2 reports
Literature references35
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- Development and biodistribution of (131)I-radiolabeled silver-doped indium oxide nanoparticles as a novel nanoplatform for tumor targeting in tumor bearing mice.
Study summary not available in the imported record. Open the original citation to review the study.
- Invited review: Evaluation of teat disinfectant efficacy studies from 2014 to 2026. A systematic review.
Study summary not available in the imported record. Open the original citation to review the study.
- Evaluating Feline Release Criteria Following 131 I Therapy for Hyperthyroidism.
Study summary not available in the imported record. Open the original citation to review the study.
- Effects of Iodine Nutritional Status on Thyroid Proliferation of SD Rat.
Study summary not available in the imported record. Open the original citation to review the study.
- Topical wound-care products and their effects on healing, inflammatory biomarkers, and growth in piglets undergoing castration.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration.